This study aimed to develop and validate a nomogram for predicting recurrence-free survival (RFS) in clinical T1 (cT1) clear cell renal cell carcinoma (ccRCC) following nephrectomy.
Additionally, it explored transcriptional profiles across distinct risk groups.
